Optimisation of the Caenorhabditis elegans model for studying the pathogenesis of opportunistic Acinetobacter baumannii

International Journal of Antimicrobial Agents

Volumn 46, Issue 4, 2015, Pages 1-

  Vallejo, J A ^a   Beceiro, A ^a   Rumbo Feal, S ^a   Rodriguez Palero M J ^b   Russo, T A ^c   Bou, G ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Acinetobacter baumannii; Caenorhabditis elegans; In vivo models; Pathogenesis; Resistance; Virulence

Indexed keywords

AMPICILLIN; COLISTIN; IMIPENEM; KANAMYCIN; STREPTOMYCIN; TRANSFER RNA;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; CULTURE MEDIUM; ENVIRONMENTAL STRESS; FEMALE; MOUSE; MURINE MODEL; NEMATODE MODEL; NONHUMAN; OSMOLARITY; PATHOGENESIS; PRIORITY JOURNAL; REPRODUCTION; SEPSIS;

EID: 84937468406     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.05.021     Document Type: Article

References (28)

1. [1] Maragakis, L.L., Perl, T.M., Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46 (2008), 1254–1263.
2. [2] Cisneros-Herreros, J.M., Garnacho-Montero, J., Pachón-Ibáñez, M.E., Nosocomial pneumonia due to Acinetobacter baumannii. Enferm Infecc Microbiol Clin 23:Suppl. 3 (2005), 46–51 [in Spanish].
3. [3] Peleg, A.Y., de Breij, A., Adams, M.D., Cerqueira, G.M., Mocali, S., Galardini, M., et al. The success of Acinetobacter species; genetic, metabolic and virulence attributes. PLOS ONE, 7, 2012, e46984.
4. [4] Beceiro, A., Tomás, M., Bou, G., Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?. Clin Microbiol Rev 26 (2013), 185–230.
5. [5] Rumbo, C., Tomás, M., Fernández Moreira, E., Soares, N.C., Carvajal, M., Santillana, E., et al. The Acinetobacter baumannii Omp 33-36 porin is a virulence factor that induces apoptosis and modulates autophagy in human cells. Infect Immun 82 (2014), 4666–4680.
6. [6] Beceiro, A., Moreno, A., Fernández, N., Vallejo, J.A., Aranda, J., Adler, B., et al. Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. Antimicrob Agents Chemother 58 (2014), 518–526.
7. [7] López-Rojas, R., Domínguez-Herrera, J., McConnell, M.J., Docobo-Peréz, F., Smani, Y., Fernández-Reyes, M., et al. Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J Infect Dis 203 (2011), 545–548.
8. [8] Russo, T.A., Luke, N.R., Beanan, J.M., Olson, R., Sauberan, S.L., MacDonald, U., et al. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun 78 (2010), 3993–4000.
9. T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect Immun 80 (2012), 1015–1024.
10. [10] Edwards, S., Kjellerup, B.V., Exploring the applications of invertebrate host–pathogen models for in vivo biofilm infections. FEMS Immunol Med Microbiol 65 (2012), 205–214.
11. [11] Rajamuthiah, R., Fuchs, B.B., Jayamani, E., Kim, Y., Larkins-Ford, J., Conery, A., et al. Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus. PLOS ONE, 9, 2014, e89189.
12. [12] Schlaich, N.L., Arabidopsis thaliana—the model plant to study host–pathogen interactions. Curr Drug Targets 12 (2011), 955–966.
13. [13] Panayidou, S., Ioannidou, E., Apidianakis, Y., Human pathogenic bacteria, fungi, and viruses in Drosophila: disease modeling, lessons, and shortcomings. Virulence 5 (2014), 253–269.
14. [14] Kaito, C., Sekimizu, K., A silkworm model of pathogenic bacterial infection. Drug Discov Ther 1 (2007), 89–93.
15. [15] Cook, S.M., McArthur, J.D., Developing Galleria mellonella as a model host for human pathogens. Virulence 4 (2013), 350–353.
16. [16] Sifri, C.D., Begun, J., Ausubel, F.M., The worm has turned—microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol 13 (2005), 119–127.
17. [17] Bozzaro, S., Eichinger, L., The professional phagocyte Dictyostelium discoideum as a model host for bacterial pathogens. Curr Drug Targets 12 (2011), 942–954.
18. [18] Hall, D.H., Altun, Z.F., C. elegans atlas. 2008, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
19. [19] Iacono, M., Villa, L., Fortini, D., Bordoni, R., Imperi, F., Bonnal, R.J., et al. Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob Agents Chemother 52 (2008), 2616–2625.
20. [20] Aranda, J., Bardina, C., Beceiro, A., Rumbo, S., Cabral, M.P., Barbé, J., et al. Acinetobacter baumannii RecA protein in repair of DNA damage, antimicrobial resistance, general stress response, and virulence. J Bacteriol 193 (2011), 3740–3747.
21. [21] Stiernagle, T., Maintenance of C. elegans. WormBook, 2006, 1–11.
22. [22] Smith, M.G., Gianoulis, T.A., Pukatzki, S., Mekalanos, J.J., Ornston, L.N., Gerstein, M., et al. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 21 (2007), 601–614.
23. [23] Eijkelkamp, B.A., Stroeher, U.H., Hassan, K.A., Elbourne, L.D., Paulsen, I.T., Brown, M.H., H-NS plays a role in expression of Acinetobacter baumannii virulence features. Infect Immun 81 (2013), 2574–2583.
24. [24] Nwugo, C.C., Arivett, B.A., Zimbler, D.L., Gaddy, J.A., Richards, A.M., Actis, L.A., Effect of ethanol on differential protein production and expression of potential virulence functions in the opportunistic pathogen Acinetobacter baumannii. PLOS ONE, 7, 2012, e51936.
25. [25] Byerly, L., Cassada, R.C., Russell, R.L., The life cycle of the nematode Caenorhabditis elegans. I. Wild-type growth and reproduction. Dev Biol 51 (1976), 23–33.
26. [26] Söderhäll, K., Invertebrate immunity. 2010, Springer, New York, NY.
27. [27] Mahajan-Miklos, S., Tan, M.W., Rahme, L.G., Ausubel, F.M., Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa–Caenorhabditis elegans pathogenesis model. Cell 96 (1999), 47–56.
28. [28] del Mar Tomás, M., Beceiro, A., Pérez, A., Velasco, D., Moure, R., Villanueva, R., et al. Cloning and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 49 (2005), 5172–5175.